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ABSTRACT
Antibiotic growth promoters (AGP) use has been associated with the emergence of
antibiotic-resistant human pathogens of animal origins. The global trend of restricting AGP
necessitates the need to develop effective alternatives that will maintain safety and sustainability
of food animals. Bile salt hydrolase (BSH) is an intestinal enzyme that is produced by diverse gut
bacterial species and involved in host lipid metabolism. Recent studies suggest that BSH inhibitors
are promising alternatives to AGP for enhanced growth performance and animal health. Using a
high-purity BSH from a chicken Lactobacillus salivarius, a panel of BSH inhibitors has been
identified. However, it is still unknown if these inhibitors also inhibit the function of the BSH from
other bacterial species with significant sequence variation and substrate spectrum. In this study,
we compared the BSH from L. salivarius to that from L. acidophilus BSH. Sequence alignment
and structure modeling indicated the two BSH enzymes contain conserved catalytically important
amino acid residues and domain. Using a high-purity BSH from L. acidophilus, we demonstrated
that the previously identified BSH inhibitors also exhibited potent inhibitory effects on the L.
acidophilus BSH.
A large scale chicken experiment was conducted to examine the effect of dietary
supplementation of riboflavin, a potent BSH inhibitor, on growth performance of broilers. Briefly,
300 one-day-old Hubbard broiler chicks were randomly assigned into three treatment groups (10
pens per group, 10 birds per pen) that received one of following diets: 1) a basal diet with no
riboflavin added (control); 2) a basal diet + low dose of riboflavin (20 mg/kg); and 3) a basal diet
+ high dose of riboflavin (200 mg/kg). Dietary supplementation of riboflavin, regardless of dose,
significantly increased BW gain by day 21 (P < 0.0053). Significantly improved FCR was only
iv

observed for the chickens that received the low dose of riboflavin on day 21 (P < 0.030). High
performance liquid chromatography was used to determine the levels of riboflavin in various diets.
The concentrations of total bile acids in the blood and ileal samples collected on day 14, 33, and
42 were not significantly changed in response to riboflavin treatment.
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CHAPTER I

LITERATURE REVIEW
Antibiotic Growth Promoters
The therapeutic nature of penicillin was discovered in the 1920s and utilized in the 1940s,
which lead to the discovery of other antibiotics from the 1930s to the 1960s (Cantas, et al. 2013).
In the early 1950’s, during the study of hepatic toxicity of alkaline hydrolyzed aureomycin
scientists observed that a tetracycline antibiotic enhanced weight gain and altered the intestinal
flora of rats (Gyorgy, et al. 1951). Subsequently, a group of subtherapeutic doses of antibiotics,
referred as antibiotic growth promoters (AGP), were used to enhance feed efficiency and weight
gain in food animals. Antibiotic growth promoters have been primarily used in the cattle, poultry,
and swine industries (Laxminarayan, et al. 2015). Effective AGPs used in food animals have low
drug substitution and include a panel of diverse antibiotics, such as bacitracin (a polypeptide),
avoparcin (a glycopeptide), bambermycin (a phosphoglycolipid), virginiamycin (a streptogramin)
and tylosin (a macrolide) (Marshall, et al. 2011). AGPs such as avoparcin, zinc bacitracin,
virginiamycin, tylosin, and spiramycin have shown a 1.5 - 5% increase in weight gain and a 3-7%
increase in feed efficiency in chickens and pigs (Buttery, et al. 1986; Hao, et al. 2014); while
ionophores have shown an increased in feed efficiency of 1.6 - 7.5% in cattle (Jouany, et al. 2007).
To date, many antimicrobials with different mechanisms of action have been found capable of
improving weight gain and efficiency of feed utilization and have been widely used in food animal
industry (Gaskins et al., 2002). Usually a combination of different AGPs is used in feeds during a
complete production cycle to maximize the efficacy of AGPs.
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At present, the precise mechanisms of growth promoting effect of AGPs are still unknown.
However, it is widely accepted that the growth promoting effect of AGPs is mediated by the
interaction between AGPs and the intestinal microbiota (Buttery, et al. 1986; Gaskins, et al. 2002;
Dibner, et al. 2005). The use of AGPs may change the diversity and structure of microbial
communities in the animal intestine and ultimately result in an optimal and balanced microbiota
for increased energy harvest and better growth performance of food animals. The proposed modes
of action of AGPs include reduction of growth-depressing microbial products, defensive function
against pathogens conferred by certain normal flora, and production of nutrients by microbiota for
host utilization (Buttery, et al. 1986; Gaskins, et al. 2002; Dibner, et al. 2005).
Precipitous AGP use caused the emergence of multiple drug resistant Escherichia coli,
Enterococcus species, Salmonella enterica, as well as

methicillin/ oxacillin-resistant

staphylococcus aureus (MRSA) in the 1950s and 1960s (Cantas, et al. 2013). Concerns of the
impact of AGP usage on public health were documented early on by England’s Swann report to
the British Parliament in 1967 and by USA’s two notices to the Food and Drug Administration
(FDA) in 1977 (Kux, et al. 2011). Epidemiological studies have linked AGP application to the
emergence of antibiotic resistant bacteria (Bager, et al. 1997; Aarestrup, et al. 1999). Antibioticresistant bacteria as well as resistance genes can therefore spread from animals to humans, which
compromises the effectiveness of antibiotics for the treatment of human infections and poses a
serious threat to public health (Levy, et al. 1976; Bager, et al. 1997; Dibner, et al. 2005; Akwar,
et al. 2007; Khanna, et al. 2008; Ogata, et al. 2012; Ramos, et al. 2013). For this reason, there is
a worldwide trend to reduce and even stop AGP use in animal production systems as described in
the following section.
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In the United States the FDA (2009) reported an increase in agricultural production and
purchases of fifteen drug classes that have broad bactericidal effects and structural compatibility
to other antibiotic classes. These AGPs such as cephalosporins, macrolides, penicillins, and
tetracyclines are some medically relevant classes that are used to enhance the weight gain of food
animals (FDA 2012). As of 2012, the FDA began encouraging the phasing out of sub-therapeutic
antibiotics for weight gain efficiency, but it has not resubmitted an additional notice since 1977
that aimed at prohibiting tetracycline and penicillins as AGPs (Dibner, et al. 2005; 2012; Cully
2014).

Current status of AGP
The findings that linked AGP avoparcin usage to the emergence of the pathogens resistant
to vancomycin, an analog of avoparcin for human therapeutic treatment, led to the ban of AGPs in
Denmark in 1998. Altogether, EU initially banned polypeptide antibiotics (e.g. avoparcin and
bacitracin), macrolides (e.g. spiramycin and tylosin), and virginiamycin combination. In 2006, the
EU completely reformed its agricultural practices and banned all AGP usage that led to a decrease
in AGP usage. The impact of AGP limited usage is still tangible.
For instance, Sweden and Denmark abstained from AGP use prior to the EU’s 2006 ban
and has demonstrated a decrease in AGP. Overall, Sweden’s drug market has sold 10% less AGPs
than in 1986 (Sweden 2012). However, in 2002, Sweden can still detect the presence of
vancomycin resistance and reported incomplete recovery of swine production after their ban
(Casewell, et al. 2003; Hao, et al. 2014; Jensen, et al. 2014). Denmark reported a decrease of
avoparcin, macrolides and virginiamycin resistance after AGP ban. However, they have been
3

contending with an increase in morbidity (2.7- 3.5%) and mortality (11%) in their swine industry
as well as resistance to tetracycline, vancomycin, and sulphonamide since the ban (Casewell, et al.
2003; Hao, et al. 2014).
The international antimicrobial market increased in value from $8.65 billion to 20.1 billion
dollars, from 1992 to 2010 and a $42.9 billion dollars increase is predicted by year 2018. The
EU’s Veterinary Medicines Directory reported an increase of 383 tons to 437 tons in therapeutic
drug sold from 1999 to 2000. Predominately, tetracycline (36 ton), sulphonamide (12 ton) and
macrolide (12 ton) were sold to the swine and poultry industries, suggesting that these industries
are most vulnerable to the ban (Casewell, et al. 2003). Thus, Demark monitors veterinary
prescription allocation, oversight, and a depreciation of medication by using VETSTAT that
censors over use and resistance to antibiotics (Jensen, et al. 2014). With an increase in the
antibacterial market a strict control of antibiotics may become a global trend.
Meanwhile, some countries, such as China, that is the user of four times the AGPs than
that used in the United States (U.S.) and Spain, which is the predominate AGP user in Europe,
have detected all drugs in the manure and waste water of livestock (Hao, et al. 2014). In the U.S.,
cattle and swine have tetracycline and ampicillin (beta-lactam) resistant genes while steers have
more tetracycline resistant genes in fecal flora than non-AGPs treated animals (Harvey, et al.
2009). Resistant genes in the fecal flora is a major concern because the AGPs belonging to
tetracyclines, lincosamides, macrolides, beta-lactam, sulfas, and aminoglycosides have similar
medically relevant drugs that are used as therapeutics in animals and humans. According to the
FDA’s total report on antibiotic sales in the United States in 2012 the two most produced and
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purchased antibiotic are tetracycline (41%) and ionophores (31%) in the food animal industry
(FDA 2012).
In December of 2013, US FDA issued Guidance 209 and 213 that outline the voluntary
phasing out of medically important antibiotics, which are used in healthy animals. In response to
this trend, Tyson and Perdue, the two major poultry producers, announced removal of humanrelated antibiotics from its broiler chicken feed in fall 2014 (Teillant, et al. 2015). In September
of 2014, President Barack Obama signed an executive order that promotes the cooperation of
industry, academia, government, the general public, and agriculture community. Aims of the
executive order are to generate novel stewardship approaches, to regulate antibiotic use, and to
monitor general public and agricultural community use of antibiotics (Jooma, 2015).

Development of alternatives to AGP
Successful AGP removal will depend on effective alternatives that are practical, cost
effective, and capable to maintain enhanced weight gain and feed efficiency. Developing effective
alternatives to AGP is urgently needed of maintaining current animal production level without
threatening public health. Several classes of alternatives to AGPs, such as probiotics, prebiotics,
and organic acids, are briefly summarized below (Jouany, et al. 2007; Cheng, et al. 2014).
Probiotics, generally consisting of Bacillus, Lactobacillus, Streptococcus, Enterococcus,
Bifidobacterium, and Bacteriodes, have been observed to improve growth performance of
monogastrics and ruminates (Cheng, et al. 2014). Live microbe supplementation in ruminants is
hypothesized to promote a lowered pH that decrease pathogenic bacteria and in monogastrics the
5

microbes are postulated to produce bacteriocins and acids that decrease level pathogenic bacteria
(Jouany, et al. 2007; Cheng, et al. 2014). The probiotic supplementations have led to enhanced
weight gain in post weaning caves (Cruywagen, et al. 1996; Sun, et al. 2010). Unfortunately, these
results have been inconsistent. For instance, supplementation of probiotics in growing ruminants
did not enhance weight gain (Morrill, et al. 1977; Schwab, et al. 1980; Zhang, et al. 2015). The
poultry industry has also observed inconsistency with the use of probiotics. They have observed
improved weight gain (Mountzouris, et al. 2007), stimulated immune response (Zhang, et al.
2012), and improved food safety (Gaggìa, et al. 2010); however due to complicated interactions
and low numbers of birds for statistical power more studies are urgently needed (Alloui, et al.
2013). Probiotic use in swine has shown an increase in weight gain that is comparable to AGP
usage (Kyriakis, et al. 2003; Kritas, et al. 2005). Conversely, data from swine studies exist to
suggest that probiotic do not improve weight gain nor feed efficiency (Harper, et al. 1983;
Lähteinen, et al. 2014). Altogether, inconsistent results on growth performance of food animals
have been observed following probiotic administration, thus warranting rationale design and
development of effective probiotic products.
Prebiotics are nondigestible oligosaccharides that sustain some beneficial bacterial
populations, such as Bifidobacterium and Lactobacillus, in the gut (Pharmaceutiques 1995).
Probiotics have been shown to bolster the microbiota, to prime the immune system of the host, and
to portray antiviral traits (Cheng, et al. 2014). Combination of probiotic and prebiotics has shown
to increase weight gain and decrease feed cost in broilers (Saiyed, et al. 2015). Prebiotic
supplementation in heat stressed broilers resulted in greater weight gain than those without
prebiotics (Hasan, et al. 2014). Additionally, probiotic with prebiotic (mannanoligosaccharides)
6

decreased the E. coli load by adhering to E. coli and merging with the fecal mass (Baurhoo, et al.
2007). Even with these benefits, prebiotics are not permitted in the European Union as they may
cause bloating and diarrhea in food animals. Additionally, the symbiotic mixture of prebiotic and
probiotics are still not well understood and need further perusal for use of them as weight enhancers
(Cheng, et al. 2014).
Acids, such as acetic, propionic, butyric and formic acids (Partanen, et al. 1999) are
enticing AGPs alternatives. The acids can generate a low pH environment that enhance pepsin
proteolytic activity and likely reduce the population of pathogenic bacteria in the gastrointestinal
tract (Knarreborg, et al. 2002; van der Eijk 2002). Benzoic acid and some essential oils (extracts
of rosemary, sage, thyme, oregano and tea) provide improved weight gain in poultry and an
increase in lactic acid and coliform bacteria (Giannenas, et al. 2014). Acids have improved feed
conversion ratio in piglets and, in adult pigs, weight gain and digestibility of feed (Partanen, et al.
1999). However, fumaric acid supplementation in young pigs diet did not show improvements in
weight gain and ileal digestibility (Giesting, et al. 1991). Studies have shown weight enhancement
due to fumaric acid supplementation, but no improvements were reported with citric acid
supplementation (Radecki, et al. 1988). However, other studies have shown that pure citric acid or
acidifiers blend did not cause weight gain but improved immunity in piglets infected with
Salmonella, (Ahmed, et al. 2014). More studies are needed to elucidate how specific acid treatment
could enhance weight gain and immune response.
Natural extracts such as saponins, tannins, and essential oils appear to be another class of
alternatives to replace AGPs. Saponins are bactericidal in that they bind to membrane steroidal
units and compromise the bacteria’s cell membrane in monogastrics. In ruminants, the use of
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saponins has lowered protein degradation by protozoa which has resulted in increase in weight
gain and feed efficiency. Unfortunately, protozoa impediment has not been observed with use of
saponins (Milgate, et al. 1995; Cheeke 1996). Tannins provide protection from helminthes and
some antibacterial effects when placed inside the rumen; in non-ruminants they reduce iron
available for bacterial metabolic purposes (Aerts, et al. 1999; Barry, et al. 1999; Jouany, et al.
2007). Essential oils have shown to be bactericidal; however, like the other natural extracts, the
mechanisms, toxicity effects, upper level concentration, and particulars of harvesting period are
not well understood (Jouany, et al. 2007; Cheng, et al. 2014).
Enzyme supplementation is being explored as a potential effective alternative to AGPs.
The addition of enzymes in feedstuff of ruminants and monogastrics has increased foodstuff
digestibility as well as bioavailability of minerals. However, the potential of the enzyme
supplementation to increase nutrient for gut microbiota make them less desirable (Jouany, et al.
2007; Cheng, et al. 2014). The combination of probiotics with phytases has shown an increase in
weight gain in broilers when compared to those given adequate phosphate diet. Although enzyme
supplementation is a promising non-antibiotic alternative approach, more studies are needed to
better justify and understand the mechanism of this strategy (Askelson, et al. 2014).
Altogether, there are significant challenges for developing effective non-antibiotic
alternatives to AGPs. Therefore, examination of gut microbiota in response to AGP treatment
would provide science-based information into the modes of action of AGP and facilitate the
development of novel alternatives to AGP (Collier, et al. 2003; Knarreborg, et al. 2004; Kim, et
al. 2012; Lin, et al. 2013).
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The effect of AGP usage on intestinal microbiota and microbiota-derived factors
The microbiota includes bacteria, archaea, and fungi populations that work symbiotically
with the host. In the last sixty-four years, subtherapeutic doses of antibiotics or AGPs have
exhibited improved weight gain in food animals (Feighner, et al. 1987; Dumonceaux, et al. 2006;
Cully 2014; Hao, et al. 2014). With the aid of culture-independent molecular approaches, the
investigations of the effect of AGP on intestinal microbiota have been initiated in different food
animals, including poultry, and swine. For example, the 16S rRNA sequencing of two pig herds at
separate farms identified Firmicutes and Bacteroidetes as dominate bacterial groups, with E. coli
population having a relatively low concentration of 0.12% (Kim, et al. 2011). Experimentation of
the pig’s intestines identified the following bacteria: Streptococcus, Lactobacillus, Eubacterium,
Fusobacterium, Bacteriodes, Peptostreptococcus, Bifidobacterium, Selenomonas, Clostridium,
Butyrivibrio, and Escherichia, with the order showing rate of occurrence (Gaskins, et al. 2002). A
16S rRNA clone library sequencing system showed Lactobacillus and Streptococcus vulnerability
to AGP treatment (Gaskins, et al. 2002; Dibner, et al. 2005). Another swine study illustrated a
preferential dominance of Lactobacillus, Clostridiaceae, and Turicibacter spp. in the ileum of
control and a decrease in L. johnsonii and L. amylovorus in chlortetracycline treatment (Rettedal,
et al. 2009). A multiple AGP formulations such as, chlortetracycline, sulfamethazine, and
penicillin in swine feed, has shown a decrease in Bacteroidetes in comparison to Firmicutes and
an increase in Proteobacteria for instance, E. coli, and Salmonella (Looft, et al. 2012). Bacterial
vulnerability during weeks of multiple AGP treatment, such as week one exposure:
chlortetracycline, sulfathiazole, penicillin; week two exposure: tylosin, bacitracin, and roxarsone;
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and third through the fifth week exposures: lincomyocin, carbadox and virginiamycin respectfully
have shown diminish of Lactobacillus, Streptococcus, and Bacillus spp. (Collier, et al. 2003).
In regards to birds, bacterial colonization occurs in the crop, gizzard, duodenum, jejunum,
ileum and cecum (Buttery, et al. 1986; Walter 2008). L. furmenta and L. salivarius populate the
crop and L. salivarius dominates the jejunum and ileum (Fuller, et al. 1974; Buttery, et al. 1986;
Gong, et al. 2007). Tylosin and penicillin AGPs have caused decreases in Lactobacillus spp. in
the ileum of fowls while penicillin treatments can also decrease Bacteroidetes, Bacteriaceae,
Enterococcus, Streptococcus spp. (Lin 2011; Singh, et al. 2013). Multiple combinations of AGPs,
such as virginiamycin and bacitracin methylene, cause an increase in Enterococcus spp. and a
decrease in the L. salivarius in the ileum (Zhou, et al. 2007). Interestingly, preparation of either
non-AGP wheat or medium chain fatty acids diets have improved feed efficiency and caused a
shift in the microbiota in broilers. The microbiota shift suppressed gram positive Firmicutes such
as Lactobacillus, Enterococcaceae and Micrococcaceae and promoted gram negative bacteria
such as Enterobacteriaceae (van der Hoeven-Hangoor, van der Vossen et al. 2013).
Lactobacillus and Bacteroidetes vulnerability to AGP underscore these species and related
derived factors as targets for developing alternatives to AGP. Some microbiota-derived proteins
in the intestinal tract may be implicated in growth promotion, such as bile salt hydrolase (BSH).
Both bacterial population produce BSH that hydrolyzes conjugated bile salts, the strong
emulsifiers of lipids and play an important role in lipid metabolism. An inverse relationship with
BSH activity and AGPs have been observed in chickens as early as in 1987 (Feighner and
Dashkevicz 1987). Together, these findings indicate that the body weight gain in food animals is
inversely related to the activity of BSH enzymes as well as the abundance of corresponding
10

bacterial producers, which provides a strong rationale for us to examine if BSH inhibitors are
promising alternatives to AGP as described in our recent studies (Wang et al, 2012; Smith et al,
2014; Lin et al. 2014) and in this project.

Molecular and biochemical features of bile salt hydrolase
Bile salt hydrolase enzyme is specific to many commensal bacteria species such as
Bacteriodes, Clostridium, Enterococcus, Bifidobacterium, and Lactobacillus in the intestines
(Gilliland, et al. 1977; Ferrari, et al. 1980; Gopal-Srivastava, et al. 1988; Coleman, et al. 1995;
Grill, et al. 2000; Elkins, et al. 2001; Franz, et al. 2001; Knarreborg, et al. 2002; Begley, et al.
2006). A single bacterium can have more than one BSH gene in its genome. Studies have
elucidated three BSH (BSHA/1, BSHB/2, and BSHC/3) genes in Bifidobacterium spp. and two
(bshA/1 and bshB/2) for Lactobacillus acidophilus (Kim, et al. 2004; Begley, et al. 2006).
Interestingly, the homology of the two BSH genes from L. acidophilus is very low, likely attributed
to horizontal gene transfer during evolution (McAuliffe, et al. 2005; Begley, et al. 2006).
Bile salt hydrolase, penicillin G acylases, and penicillin V acylases are N terminal
nucleophiles that have a cysteine residue, visible post transcriptional modifications at the Nterminus (Suresh, et al. 1999). The N-terminal can begin with either cysteine, threonine, or serine
and is the beginning of the BSH’s catalytic site that has key amino acid residues such as Cys-2,
Arg-16, Asp-19, Asn-79, Asn-171, and Arg 224 (Begley, et al. 2006). These conserved amino
acid residues can play a role in providing a universal target within the BSH’s catalytic site.
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Bile salt hydrolase is thought to benefit the bacteria’s nutrition and membrane integrity
(Begley, et al. 2006). Clostridium isolates from rats demonstrated colony growth after
unconjugation of taurine’s sulfur containing bile salts, while sulfur compounds and sulfhydryl
containing amino acid did not stimulate growth (Huijghebaert, et al. 1982). Membrane integrity
can be bolstered as low pH can cause precipitation of the unconjugated cholesterol that may initiate
host’s cholesterol integration into bacteria membrane; the cholesterol integration can decrease the
host’s immune-recognition of the bacterial cell (Taranto, et al. 1997; Taranto, et al. 2003).
Though BSH appears to be an adaptation mechanism of bacteria in the presence of
detergent like bile salts they can have advantageous and harmful effects on the host. Post
unconjugation, additional modification such as dehydroxylation and dehydrogenation of bile salt
by BSH have been associated with an increase in gall stone formation and colon cancer in humans
(Marcus, et al. 1986; Begley, et al. 2006). However, some bacteria can only hydrolyze the
conjugated bile salt and have not evolved the capabilities to further modify the acid, thus these
BSH producers can be critical in preventing cholesterolemia (Kim, et al. 2004).

Role of BSH in lipid metabolism and host energy harvest
The BSH enzyme is produced by gut bacteria and catalyzes the deconjugation of
conjugated bile acids, an essential gateway reaction in the metabolism of bile acids (Begley, et al.
2006). The intestinal BSH activity, the widely distributed function of the gut microbiota, has been
demonstrated to play an important role in host fat metabolism, energy harvest, and body weight
gain. Previous studies have shown that oral administration of BSH-producing lactobacilli could
12

affect lipid metabolism, which consequently lowered cholesterol level in humans. The cholesterollowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB
30242 in yoghurt formulation was reported in hypercholesterolaemic adults (Jones, et al. 2012).
Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolaseproducing Lactobacillus plantarum strains in Sprague-Dawley rats (Kumar, et al. 2011); and in
pigs (Smet, et al. 1998) showed cholesterol lowering effects through enhanced bacterial bile salt
hydrolase activity, which is likely mediated through BSH activity of the tested probiotics.
Recently, Joyce et al analyzed the impact of in situ BSH activity on host metabolism and weight
gain, and provided compelling direct evidence that showed the critical role of intestinal BSH in
regulating host weight gain and lipid metabolism. Colonization of germ-free mice or conventional
mice with a BSH-producing E. coli strain elevated intestinal BSH activity, consequently reducing
body weight, reducing serum cholesterol level, changing bile acid profiles in feces and plasma,
and influencing both local and systemic gene-expression profiles in pathways governing lipid
metabolism in this animals (Joyce, et al. 2014). This work clearly identifies BSH as a mechanism
through which the microbiota modulates host lipid metabolism and demonstrates that BSH
represents a key target for developing novel alternatives to AGPs for enhanced animal production
and feed efficiency.
As described above, population of intestine Lactobacillus species, the major intestinal
BSH-producer, was significantly reduced in response to AGP use (Knarreborg, et al. 2002;
Dumonceaux, et al. 2006; Guban, et al. 2006). Consistent with this finding, growth-promoting
effect of AGP was highly correlated with the decreased activity of BSH enzyme in the chicken
intestine (Feighner, et al. 1987).
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Bile salt hydrolase catabolizes the bile salt into amino acid and cholesterol moieties that
produces a primary bile acid. This structure is not readily reabsorbed and can stimulate nuclear
receptor farnesoid X receptor (FXR) in the host’s intestinal lumen. The FXR stimulation causes
the up regulation of Cyp7A1 that promote de novo synthesis of bile salts by the removal of
cholesterol from the blood (Lu, et al. 2000; Watanabe, et al. 2006; Joyce, et al. 2014). Further
modifications of primary bile acids into secondary and tertiary structure are associated with colon
cancer and gallstone formation. However, the Lactobacillus and Bifidobacterium BSH enzymes
cannot modify primary bile acids, this consequentially lowers cholesterolemia and the occurrence
of colon cancer in humans (Choi, et al. 2014). In summary, hydrolysis of conjugated bile salts
leads to less amphiphilic molecules (unconjugated bile acids), which compromises fat digestibly
and absorption. The primary structures stimulate FXR that ultimately leads to the liver
sequestering cholesterol from the blood to synthesize bile salts de novo. When the primary bile
salt is modified into secondary bile salt it can accumulate and cause cancer of epithelial tissue due
to DNA damage. However, if additional modifications do not occur, the primary molecule merges
with the fecal mass and is excreted, and this potentiates a promising therapeutic measure in obesity
and hypercholesterolemia therapy.
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CHAPTER II

INTRODUCTION
The food animal industry has manipulated the gut microbiota to increase body weight and
feed efficiency through the use of sub-therapeutic level of antibiotics, called antibiotic growth
promoters (AGP), as feed additives for more than 60 years (Dibner, et al. 2005). However, AGP
usage has been linked to the emergence of antibiotic resistant bacteria (Wegener 2003). Thus, a
worldwide trend to limit AGP use in food animals in order to protect public health and improve
food safety has created challenges for the animal industries (Wegener 2003; Turnidge 2004).
Effective alternatives to AGP are urgently needed to maintain current animal production levels
without threatening public health.
The examination of AGP effects on intestinal microbiota in food animals could enhance
understanding of the mode of action of AGP and facilitate the development of novel alternatives
to AGP. Although reduction of gut pathogens due to AGP usage is potentially a mechanism
contributing to growth promotion, it has been widely accepted that use of AGP would restructure
the complex gut microbial environment for optimal host growth performance from a nutrition
standpoint. Recent independent food animal studies (Feighner, et al. 1987; Knarreborg, et al. 2002;
Knarreborg, et al. 2004; Guban, et al. 2006) have shown that growth-promoting effects of AGP
were highly correlated with the decreased activity of bile salt hydrolase (BSH), a gut bacterial
enzyme that has negative impact on host fat digestion and energy harvest (Dibner, et al. 2005;
Begley, et al. 2006). Notably, using both gnotobiotic and conventionally raised mice, Joyce et al
recently obtained direct supporting evidence that BSH activity, the widely distributed function of
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the gut microbiota, significantly influences host lipid metabolism and weight gain. Based on these
extensive supporting evidence, we have proposed that BSH is a promising microbiome target for
developing novel alternatives to AGP; specifically, BSH inhibitors are promising feed additives
that may replace AGP for enhanced host lipid metabolism and growth performance (Lin 2014).
The BSH enzyme produced by gut bacteria catalyzes deconjugation of conjugated bile
acids, an essential gateway reaction in the metabolism of bile acids. The natural functions of this
BSH-mediated metabolic activity in the producing bacteria are still not clear despite various
theories with contradictory findings (Begley, et al. 2006). However, it has been increasingly
recognized that intestinal BSH plays an important role in host metabolism and energy harvest
(Begley, et al. 2006; Jones, et al. 2008; Joyce, et al. 2014; Lin 2014). Because conjugated bile
acids function as a more efficient “biological detergent” than unconjugated bile acids to emulsify
and solubilize lipids for fat digestion (Begley, et al. 2006), BSH activity has significant impact on
host physiology by reducing fat digestion and lipid metabolism, consequently affecting body
weight gain (Begley, et al. 2006; Jones, et al. 2008; Joyce, et al. 2014). Recently, we have
identified and characterized a powerful BSH enzyme with broad substrate specificity from a
Lactobacillus salivarius strain that was isolated from a chicken (Wang, et al. 2012). In addition,
with the aid of the purified L. salivarius BSH, we have identified a panel of BSH inhibitors through
targeted screening (Wang, et al. 2012) as well as high-throughput screening procedures (Smith, et
al. 2014). The L. salivarius BSH displayed potent hydrolysis activity towards both
glycoconjugated and tauroconjugated bile salts; the broad substrate specificity nature of this BSH
may make it an ideal candidate for screening desired BSH inhibitors that can targeting various
BSH enzymes (Wang, et al. 2012; Smith, et al. 2014).
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However, given different types of BSH enzymes present in the intestine (Begley, et al.
2006; Jones, et al. 2008), a significant question is raised: can these identified inhibitors also
effectively inhibit the function of the BSH from other bacterial species with significant sequence
variation and substrate spectrum? Addressing this issue is critical for us to identify desired BSH
inhibitors using the established L. salivarius BSH-based high-throughput screening system (Smith,
et al. 2014). In this study, comparative genomic, structural, and biochemical analysis of a BSH
from a different strain L. acidophilus were performed. The inhibitory effect of previously identified
BSH inhibitors on the purified BSH from different species was determined.
In addition, using a well-established HTS system, a panel of novel BSH inhibitors with
potential as alternative to AGP was successfully identified. Riboflavin is of particular interest
because it has potent inhibitory effect on BSH (Smith, et al. 2014). Riboflavin, a yellow compound
harvested from milk, eggs, and cereals as free or bound compound and in most other foods found
as coenzyme flavin adenine dinucleotide or flavin mononucleotide. It can become hydrogenated
and hydroxylated among other forms (Massey 2000). Notably, riboflavin is a vitamin that has been
used as feed additive in poultry to treat the hypovitaminosis B2. However, long-term dietary
supplementation of riboflavin for growth promotion in broilers has never been explored. While
our in vitro studies support the feasibility of using riboflavin as an alternative to AGPs, a large
animal trial is needed to determine the effect of dietary supplementation of riboflavin on growth
performance and host lipid metabolism. Notably, a recent swine study has shown that the dietary
supplementation of high-level riboflavin (20 mg/kg feed) significantly increased feed efficiency
and body weight gain in the pigs with high lean growth although underlying mechanisms are still
not clear (Stahly, et al. 2007). Therefore, in this study, a large chicken nutritional trial was
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conducted that determined the effects of dietary supplementation of riboflavin on chicken growth
performance. Weekly body weight gain, feed intake, and feed conversion ratio were assessed.
Furthermore, total bile acids in serum and ileal content were measured in response to riboflavin
treatment.
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CHAPTER III

MATERIALS AND METHODS

Bioinformatics analysis of BSH
A BSH gene from L. acidophilus PF01 has been identified and characterized Oh, et al.
(2008); the nucleotide sequence of this BSH gene was deposited in the GenBank database
(Accession No. EF536029). The BSH gene from the L. acidophilus PF01 strain (Oh, et al. 2008)
was compared to those identified from L. salivarius NRRL B-30514 (Wang, et al. 2012) and to
other diverse bacteria using the BLASTP program from the National Center for Biotechnology
Information (NCBI, http://www.ncbi.nlm.nih.gov/). To reveal the phylogenetic relationship,
multiple sequence alignment of BSH sequences from different bacterial species and penicillin V
acylase from Bacillus sphaericus (BPVA) were performed with the use of the ClustalW program
in MEGA 6.0 (Tamura, et al. 2013). The dendrogram was constructed by neighbor-joining
methods. To identify the conserved amino acid motifs that potentially is involved in BSH activity,
multiple sequence alignment of BSH enzymes were performed with the use of the ClustalW2
program (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
The modeling of BSH was performed in the Molecular Operating Environment (MOE),
version 2008.10 (Chemical Computing Group, Montreal, QC). The BSH from Clostridium
perfringens (Rossocha, et al. 2005) was chosen as template. Total 10 models were generated in
the MOE homology module, using the AMBER99 force field. The one with highest packing score
was chosen to superimpose with the C. perfringens BSH (Rossocha, et al. 2005), by way of the
substitution matrix blosum62.
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Purification of recombinant BSH (rBSH)
A pET-21b (+) vector-derived recombinant plasmid encoding recombinant L. acidophilus
BSH (Oh, et al. 2008) was kindly provided by Dr. Dae-Kyung Kang (Dankook University, Korea).
This recombinant plasmid bears a histidine-tagged rBSH gene with a full-length of BSH gene that
was cloned from Lactobacillus acidophilus PF01, a commensal strain isolate from swine intestine
(Oh, et al. 2008). In this study, this recombinant plasmid was introduced into the E. coli BL21
(DE3) host strain via transformation. The desired transformants were selected after an overnight
incubation at 37 oC with the use of Luria-Bertani (LB) agar plates that were supplemented with
ampicillin (100 μg/ml). The recombinant plasmid in one transformant, designated as JL1139, was
extracted and subsequently sequenced; no mutations in the coding sequence of the BSH gene were
detected. Expression and purification of the His-tagged rBSH from JL1139 were performed by the
procedure described in previous publications (Lin, et al. 2005; Oh, et al. 2008; Wang, et al. 2012).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with a 12% (wt/vol)
polyacrylamide separating gel was performed to monitor production and purification of the rBSH.
The purified rBSH was finally dialyzed against PBS buffer with 10% glycerol (pH 7.0) and stored
in -80 oC freezer prior to use. Protein concentration was measured by BCA protein assay kit
(Pierce).

Effect of identified BSH inhibitors on the activity of BSH
The following three groups of compounds that have been identified as inhibitors for the L.
salivarius BSH (Wang, et al. 2012; Smith, et al. 2014) were used in standard BSH assay in this
study: 1) the approved feed additives used in food animals including CuCl2, CuSO4, ZnCl2, ZnSO4,
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NaHIO3, KIO3 and NaIO4; 2) the novel BSH inhibitors identified using high-throughput screening,
which include caffeic acid phenethyl ester, riboflavin, epicatechin monogallate, gossypetin,
menadione, and purpurogallin (Smith, et al. 2014); 3) the antibiotics that can inhibit BSH activity
including

oxytetracycline,

demeclocycline

hydrochloride,

methacycline

hydrochloride,

doxycycline hydrochloride, roxarsone, and lincomyocin (Smith, et al. 2014).
A modified two-step standard BSH assay (Wang, et al. 2012) was performed to determine
the inhibitory effect of the selected BSH inhibitors on the activity of the rBSH from L. acidophilus.
Briefly, 10 µl of specific inhibitor, 10 µl of rBSH (1.20 µg/ul), 168 µl of reaction buffer (0.1 M
sodium-phosphate, pH 6.0) and 2 μl of 1 M DTT were mixed gently and incubated at 37oC for 30
min. Then 10 μl of glycocholic acid (100 mM) was added in the 190 μl of reaction mix and the
final reaction mix (total volume of 200 µl) was incubated at 37 oC for another 30 min. A 50-μl
aliquot of the reaction mixture was then immediately mixed with 50 μl of 15% (w/v) trichloroacetic
acid for stopping the reaction, followed by centrifugation for 5 min at 12,000 × g at room
temperature to remove the precipitate. The supernatant was used in the second step, in which 50
μl of supernatant was thoroughly mixed with 950 μl of ninhydrin reagent mix (0.25 ml of 1%
[wt/vol] ninhydrin in 0.5M sodium-citrate buffer, pH 5.5; 0.6 ml of glycerol; and 0.1 ml of 0.5 M
sodium-citrate buffer, pH 5.5). A positive control (with BSH enzyme, without BSH inhibitor) and
a negative control without BSH added were set up in each independent experiment. All assays
were performed in triplicate. Percentage inhibition was calculated by dividing the inhibited activity
(mean activity of positive control – mean residual activity of presence of a compound) relative to
the mean activity of positive control and then multiplied by 100.
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Chicken experiment: husbandry, diets, growth measurements and sample collection
Three hundred mixed sex day old broilers from the hatchery at Hubbard in Pikeville, TN
were brought to Joseph E. Johnson Animal Research and Teaching Unit (JARTU). Ten broilers
were randomly selected and placed in each of thirty floor pens with approximately12.5 square feet
floor space per pen. Shredded papers were used as litter material. The chickens were randomly
assigned into three treatment groups (10 pens per group) that received one of following diets: 1) a
basal diet with no riboflavin added (control); 2) a basal diet + low dose of riboflavin (20 mg/kg of
diet); and 3) a basal diet + high dose of riboflavin (200 mg/kg of diet). The riboflavin was
purchased from http://www.BulkSupplements.com (99% purity). The diet formulations for a
common starter, grower, and finisher corn-soybean diet were described in Table 1. Water and feed
were available for ad libitum consumption during the experiment. Weights of birds, feed
consumption per pen and feed conversion ratio (gain/intake) were determined at age of 7, 14, 21,
33, and 42 days and recorded. On days 14, 33, and 42, one average sized bird per pen was further
selected for sample collection. Following blood collection from the wing vein, the birds were
euthanized with carbon dioxide gas and ileal content collected. Each ileal sample was transferred
into 1.5 ml microcentrifuge tubes and then put on ice, while at JARTU and during transportation.
The blood samples were centrifuged at 11,337 × g for 5 min and serum was pipetted into sterile
microcentrifuge tube. The collected serum and ileal samples were stored in -20 °C freezer.

Riboflavin analysis in feed using high performance liquid chromatography (HPLC)
The level of riboflavin in the formulated feeds was analyzed with HPLC technique. Feed
samples from each growth phase (starter, grower, and finisher) and treatment (control, low dose
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of riboflavin, and high dose of riboflavin) were collected immediately following on site
preparation in JARTU and stored in -20 °C freezer prior to analysis. Initially, the feed samples
were dried at 55 °C for 24 hr with in an oven (Thermo Fisher Scientific Inc.). Each sample was
grounded using a Wiley Mill grinder that was thoroughly cleaned between samples. The grounded
sample was mixed with 0.1 M HCl, vortexed for 1 min followed by incubation at room temperature
for 30 min. The homogenized solution was then centrifuged at room temperature at 2,504 × g for
15 min. Subsequently, 1 ml of the supernatant was pipetted into 3 ml of 25 mM NaH2PO4 (pH
2.5). This mixture was vortexed and centrifuged at room temperature for 15 min at 2,504 × g. The
supernatant was filtered using 0.2 µm filter, and stored in 4°C (up to 24 hr) for chromatographic
analysis. Riboflavin standards (1 ppm, 2 ppm, and 5 ppm) were prepared using 25 mM NaH2PO4
(pH 2.5) and the riboflavin was purchased from SIGMA (catalogue number PHR1054). Riboflavin
levels from each of the treatments in the starter, grower, and finisher paradigms were tested in two
independent HPLC experiments with single sample used in each independent experiment.
The HPLC procedure was performed with the use of an Agilent Technologies liquid
chromatography equipped with an auto sampler (model: G1329A). The analytical column was a 5
µm Zorbax Eclipse Pluse C18 in 4.5 mm x 150 mm column. A Quatemary pump (model: G1311A),
diode array detector (model: G1315P), and a multiple wavelength detector (model: G1315D) were
used. The mobile phase was 25 mM of NaH2PO4 (pH 2.5). The samples were injected by the auto
sampler by way of a mobile phase with delivery rate of 1 ml/min. UV was detected at 280 nm.
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Determination of total bile salts concentration
Total bile salt levels in the collected serum and ileal samples were detected with Diazyme®
kit (San Diego, California). Principally, the enzyme, 3-α-hydroxysteroid dehyrogrenase, oxidizes
bile salts with the coenzyme Thio-NAD that was converted into Thio-NADH. The Thio-NADH is
a colorimetric label that can be read at the absorbance of 405 nm. Briefly, 3.6 ul of collected sample
or the standard along with 243 ul of Reagent 1 were added into each well of a 96 well plate then
incubated for 3 min at 37 °C. Subsequently, 81 ul of Reagent 2 was added to each well and
immediately placed in the plate reader, BioTek Instrucments ®ELX808. Readings were performed
at one minute interval for a total of two minutes with the Gen 5® version 2.03.1 software. The
opacity difference between the two readings was used to determine the total bile salt concentration
(µmol/L) with the use of a Diazyme kit equation. Total bile salt levels were detected in the serum
and ileum samples that were collected from ten chickens per treatment on sample collection days
(14, 33, and 42).

Statistical Analysis
Feed intake, bird weight gain, feed conversion ratio, and total bile salt levels from serum
and ileal samples have been analyzed by mix model analysis of variance with statistical program
SAS 3.9. The large scale chicken experiment’s independent variables were riboflavin
concentrations and dependent variables were weight gain, feed intake, and feed conversion ratio.
All variance were detected by least square means that compared least significant difference at 5%
level of confidence.
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CHAPTER IV
RESULTS

Phylogenetic and structural analysis of BSH
The complete BSH genes from diverse bacteria species were retrieved from database for
analysis. As shown in Figure 1A, the BSH produced by L. acidophilus PF01 (LaciP) shared high
homology (93% aa identity) to a BSH from L. gasseri (Lgass) but is phylogenetically distant from
the BSH that was identified in many other bacteria, such as the BSH from L. salivarius NRRL B30514 (LsalN1). Although the BSH enzymes from various bacterial species showed significant
sequence variation (Figure 1A), multiple sequence alignment indicated that these BSH enzymes
contain all conserved catalytically important amino acid residues in the proposed active site of
BSH (Cys-2, Arg-16, Asp-19, Asn-79, Asn-171, and Arg 224) (Begley, et al. 2006) (Data not
shown). This conservativeness of catalytically important motifs suggests that previously identified
BSH inhibitors may effectively inhibit diverse BSH enzymes.
Structural modelling of the L. acidophilus BSH (LaciP) and the L. salivarius BSH (LsalN1)
was performed with the use of the only known crystal structure of the Clostridium perfringensproduced BSH (Rossocha, et al. 2005) (Cperf in Figure 1A). The models indicated that the L.
acidophilus BSH and the L. salivarius BSH shared similar structure with the evidence of the
typical canonic αββα-folding pattern (Figure 1B). Consistent with the structural similarity between
the two different BSH enzymes (Figure 1B), the critical amino acids are also superimposed very
well, particularly with respect to the typical Cys2, which served as an N-terminal nucleophile, and
the Arg16, which plays a potentially essential role in catalytic functioning of the enzyme
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(Rossocha, et al. 2005). This structure modeling provides further evidence that supports the
feasibility of using the L. salivarius BSH for screening desired BSH inhibitors.

Expression and purification of L. acidophilus recombinant BSH (rBSH)
A pET-21b(+) vector that was bearing the full length of a L. acidophilus BSH gene, was
transformed to an E. coli BL21 (DE3) host strain for production of recombinant BSH (rBSH).
Upon induction by 0.5 mM of IPTG for as short as 1 hr, the recombinant E. coli construct
significantly produced an additional protein with approximate molecular mass of 32 kDa on SDSPAGE, which was consistent with the calculated molecular mass from the deduced amino acid
sequence of the rBSH (Figure 2). The high-purity of the C-terminal His-tagged rBSH was
subsequently obtained from the E. coli culture with the use of a one-step Ni-NTA agarose affinity
chromatography. As shown in Figure 2, the high-purity of rBSH was predominantly present in
the eluted fractions number 3 to 6. Interestingly, a band with slightly smaller molecular mass was
co-present with the rBSH; this band likely represents a partially degraded rBSH (Figure 2).
Approximately 25 mg of the rBSH was consistently purified from 1 liter of induced culture.

The identified BSH inhibitors also inhibited the activity of the L. acidophilus BSH
As shown in Table 2, almost all of previously identified BSH inhibitors using the L.
salivarius BSH (Wang, et al. 2012; Smith, et al. 2014) also exerted potent inhibitory effect on the
phylogenetically distant BSH from L. acidophilus, which strongly supported the hypothesis that
the L. salivarius BSH is an ideal candidate for screening desired BSH inhibitors and can target
various BSH enzymes in the intestine. Only limited BSH inhibitors, such as ZnSO4 and roxarsone,
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displayed weaker inhibitory effect for the L. acidophilus BSH (Table 2) when compared to the L.
salivarius BSH. Based on these findings, the L. salivarius BSH in conjunction with an efficient
high-throughput screening system (Smith, et al. 2014) would serve as a solid platform for us to
identify desired BSH inhibitors with potential to replace AGP for enhanced host lipid metabolism
and growth performance.
A recent study (Smith, et al. 2014) has suggested that two novel BSH inhibitors, riboflavin
and caffeic acid phenethyl ester (CAPE), have high potential as novel alternative to AGP. In the
current study, potent inhibitory effect of these two compounds on the L. acidophilus BSH (Table
2) was also observed. Since we are particularly interested in CAPE and riboflavin as AGP
alternatives, subsequent dosing experiments were conducted to examine BSH activity at lower
concentrations. As shown in Figure 3, CAPE still inhibited rBSH activity by more than 50% at a
final concentration of 0.625 mM (Fig. 3A) and riboflavin by more than 50% at a final concentration
as low as 0.03125 mM (Fig. 3B).

Growth performance of broilers in response to riboflavin treatment
As shown in Table 3, the BW did not differ significantly (P > 0.05) in response to dietary
treatment of riboflavin regardless of dosage. However, BW gain significantly increased (P =
0.0053) for the birds receiving riboflavin (either low or high level) at 21 days of age. In addition,
the birds on the 20 ppm of riboflavin treatment had lower feed intake than those in control group.
However, dietary supplementation of high level of riboflavin (200 ppm) led to inconsistent feed
intake pattern compared to the control group. For example, feed intake at day 14 in high-level
riboflavin group (0.3759 kg/bird per week) was significantly lower than control group (0.4101
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kg/bird per week) (P = 0.0393); however, feed intake significantly increased (P = 0.0001) in the
200 ppm riboflavin treatment when compared to control group on day 21 (Table 3). In terms of
feed conversion efficiency (BW gain over feed intake), only low riboflavin treatment led to
significantly increased feed conversion efficiency on day 21 (Table 3).

HPLC determination of riboflavin in feed
In this study, all chicken feed were prepared on site in JARTU. Given small amount of
riboflavin supplemented in various feeds (Table 1), it is important to ensure that riboflavin was
mixed within the feed evenly so that desired level was achieved. To determine the level of
riboflavin in the feed, a HPLC method was established for this project. As shown in Figure 4A, a
sharp peak was observed for the standard riboflavin. The riboflavin that was extracted from the
feed, was successfully detected at similar eluent phase (Figure 4B). Based on comparison of peak
intensity, the riboflavin level was determined in various feeds. Due to the trace presence of
riboflavin in basal feed, it is not surprising that approximately 26-34 ppm of riboflavin were
determined in the Control feed. The addition of low level riboflavin (20 ppm) led to the increase
of riboflavin in all starter, grower and finisher feeds (Table 4). As expected, the riboflavin level
in High group (200 ppm riboflavin supplementation) was higher than those in Control and Low
group (20 ppm riboflavin supplementation).

The level of bile salts in serum and intestine
A totally of 90 serum samples and 90 ileal samples from individual chickens were
subjected to determination of bile salt levels. As expected, the level of total bile in blood is much
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lower than that in ileum (Table 5). However, there is no significant difference between the control
and treatment (P > 0.05) (Table 5), mainly due to significant variation among individual chickens.
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CHAPTER V

DISCUSSION

The development of alternative feed additives is urgently needed to maintain enhanced
weight gain and feed conversion ratio levels while phasing out the use of AGPs. The understanding
of the AGP mechanism is essential to the development of an effective and sustainable alternatives
to AGP. It is widely accepted that the use of AGPs changes the ecology of gut microbiota, which
leads to enhanced weight gain and feed efficiency (Collier, et al. 2003; Knarreborg, et al. 2004;
Dumonceaux, et al. 2006; Guban, et al. 2006; Kim, et al. 2012; Lin, et al. 2013). Our lab recently
found the correlation between AGP-mediated growth promotion and the decreased L. salivarius
population, a major BSH-producer, in the chicken intestine (Lin, et al. 2013; Lin 2014). Given that
the usage of AGPs is also strongly associated with the decreased BSH activity (Feighner, et al.
1987; Knarreborg, et al. 2004; Guban, et al. 2006), we hypothesized that BSH is an attractive
microbiome target for developing alternatives to AGP and have made significant progress in
obtaining additional compelling evidence to support this hypothesis (Wang et al, 2012; Lin et al.,
2013; Smith et al, 2014: Lin 2014). In particular, we recently have developed an efficient High
Throughput Screening (HTS) system that identifies BSH inhibitors using a BSH from a chicken
L. salivarius strain (Smith et al, 2014). In this project, with the use of a L. acidophilus BSH, we
obtained more evidence that demonstrated the feasibility of this HTS system.
Bile salt hydrolase is part of the choloylglycine hydrolase enzyme family that has a
conserved cysteine N-terminal residue. It is produced by various commensal bacteria, such as
Lactobacillus, Bacteriodes, Clostridium, Enterococcus, and Bifidobacterium (Begley, et al. 2006).
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The natural function of BSH for these commensal bacteria is still controversial and not clear;
however, the BSH enzyme plays an important role in host physiology by affecting host lipid
metabolism and energy harvest (Coleman, et al. 1995; Jones, et al. 2008; Chae, et al. 2013).
Although the research in BSH is still in its infancy (Patel, et al. 2010; Joyce, et al. 2014), previous
BSH studies have shown that intestinal BSH displayed significant sequence variation and
specificity for substrate choice (Begley, et al. 2006; Jones, et al. 2008; Chae, et al. 2013). Notably,
a recent functional metagenomics work (Jones et al, 2008) identified functional BSH in all major
bacterial divisions and archaeal species in the gut and demonstrated the BSH enrichment in the gut
microbiome. Phylogenetic analysis illustrates that selective pressure in the form of conjugated bile
acid has driven the evolution of members of the Ntn_CGH-like family of proteins toward BSH
activity in gut-associated species.
In this study, we chose the BSH from L. acidophilus PF01 (Oh, et al. 2008) for validation
work because of the following several reasons. First, the BSH enzyme from L. salivarius that was
used for screening BSH inhibitors (Wang, et al. 2012; Smith, et al. 2014), is comparatively
different than the BSH produced by different bacterial species. Second, the BSH-producing L.
acidophilus PF01 and L. salivarius NRRL B-30514 strains were originally isolated from the
intestine of two different food animals, swine and chicken, respectively. Finally, the L. acidophilus
BSH (316 amino acids, aa) and the L. salivarius BSH (324 aa) displayed significant sequence
variation (only 35% aa identity) and different substrate specificity (Oh, et al. 2008; Wang, et al.
2012; Smith, et al. 2014). Therefore, the L. acidophilus BSH makes an appropriate candidate
enzyme that can be used to determine if previously identified BSH inhibitors (Wang, et al. 2012;
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Smith, et al. 2014), which is based on the L. salivarius BSH, could effectively inhibit the activity
of diverse BSH enzymes in the intestine.
Our laboratory’s recent work (Smith, et al. 2014) indicated that riboflavin and caffeic acid
phenethyl ester (CAPE), two BSH inhibitors, are promising alternative to AGP. In this study, using
a BSH from a different bacterial species, we further demonstrated that riboflavin and CAPE are
effective BSH inhibitors (Figure 3 and Table 2). Riboflavin is a vitamin that has been used as feed
additive in poultry feed stuff to treat the hypovitaminosis of B2. However, long-term dietary
supplementation of riboflavin for growth promotion in broilers has never been explored. Notably,
a recent swine study has showed that the dietary supplementation of high-level riboflavin (20
mg/kg feed) significantly increased feed efficiency and body weight gain in the pigs with high lean
growth, however underlying mechanisms are still not clear (Stahly, et al. 2007). CAPE has
antioxidant/anti-inflammatory effects and is an emerging natural food additive that recently has
drawn extensive attention for human and animal application. Therefore, a standard large pen trial
is highly warranted to determine if dietary supplementation of such BSH inhibitors could enhance
feed efficiency and growth performance in chickens.
In this study, riboflavin was formulated in the feed at low (20 ppm) and high (200 ppm)
doses for a large chicken experiment (Table 3). However, we only observed significant body
weight gain due to riboflavin treatment by day 21. This finding is consistent with an early report
by Olkowski et al (1998) in which enhanced growth was observed in broilers receiving riboflavinsupplemented feed (5 mg/kg of fee) during the first 21 days. In addition, in this study the
significantly enhanced feed efficiency (P < 0.05) was only observed for the birds receiving low
level of riboflavin at 21 days of age (Table 3). However, in general, dietary supplementation of
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riboflavin, a BSH inhibitor, did not significantly improve broiler growth performance in this
project as expected, which may be attributed to following several factors. First, we incorporated
male and female Hubbard broilers in this chicken study. Statistically significantly higher weight
gain in male than female broilers have been observed in previous studies (Lowe, et al. 1986; López,
et al. 2011; Salim, et al. 2012). In the future, we may address this issue by the use of same sex
broilers, such as male Cobb broilers. Using male broilers will eliminate any confounding factors
that involve hormones such as estrogen, which has shown to decrease weight enhancement
(Mohammadrezaei, et al. 2014). In future chicken trial, we may also remove the broilers with
significantly impaired growth (the outlier chicken) within the first week for proper statistical
analysis. Second, intestinal bioavailability of riboflavin may have been low because it is
moderately water soluble 0.07 g/L in water. In addition, it has been reported that there are three
different transporters present in rat’s intestines and kidneys to maintain homeostasis. Riboflavin
does not have an upper toxicity level as the kidneys could filter excess riboflavin (Yonezawa, et
al. 2008; Yonezawa, et al. 2013). Thus, similar transporters in chickens may make riboflavin be
quickly taken up by gut epithelial cells, which can lead to undesired low concentration of riboflavin
in the intestine. To address this potential problem, encapsulation of riboflavin may achieve a
targeted and steady release of riboflavin that would increase intestinal lumen exposure time as well
as the probability of interaction with the microbiota (Khansari, et al. 2013; Bou, et al. 2014;
O’Neill, et al. 2015).
We hypothesized that riboflavin, a BSH inhibitor, would inhibit BSH activity and
consequently change the relative proportion of conjugated bile salts. However, determination of
profiles of different bile salts in the intestine and blood is technically demanding (Joyce et al.
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2014). It has been reported that BSH activity may also influence total bile salt concentration in
addition to directly reducing conjugated bile salts (Joyce et al. 2014). Thus, in this study, using a
commercially available kit, we determined total bile acid concentration in ileum and blood;
however, no significant difference was observed among treatment groups (Table 5). This is likely
due to the significant variation among chickens and because of complex bile metabolism in
chicken host. In the future, a more accurate technology, such as ultra-performance liquid
chromatography mass spectronomy (UPLCMS) (Joyce et al. 2014), should be used to measure
specific conjugated and unconjugated bile salts in the intestine in conjunction with chicken growth
performance evaluation.
Though the pilot HTS process has identified some potent BSH inhibitors (Smith, et al.
2014), a larger scale HTS with an extensive compound library is still needed to identify BSH
inhibitors with potential as alternatives to AGP. To identify desired BSH inhibitors, in conjunction
with HTS screening and in vitro assay, we must perform extensive review of relevant material
safety data sheet and literature for the hits with emphasis on availability, stability, intestinal
absorption, toxicity, cost, and environmental impact. In addition, the FDA Food Additive Listings
(http://www.fda.gov/Food/) will be used to choose priority candidates that may be quickly
approved for practical application. More importantly, a single BSH inhibitor such as riboflavin,
as in this project, may have multiple impacts on animal host physiology and complex interaction
with gut microbiota (Burgess, et al. 2006; Arena, et al. 2014; Russo, et al. 2014). Thus,
comprehensive animal trials are always highly warranted for promising BSH inhibitors.
Notably, BSH inhibitors may be used to optimize current probiotics (the BSH producers).
In animal industry, probiotics have been used to enhance growth and over all animal welfare
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(Fajardo, et al. 2012; Roodposhti, et al. 2012; Amerah, et al. 2013; Sadrasaniya, et al. 2013;
Lähteinen, et al. 2014). Despite multiple beneficial effects of probiotics, probiotics can have side
effects in the animal host, such as decreased fat digestibility due to production of BSH (Dibner, et
al. 2005). Therefore, not surprisingly, the results on animal growth performance following
probiotic administration have been inconsistent. For instance, supplementation of probiotics in
growing ruminants did not enhance weight gain (Morrill, et al. 1977; Schwab, et al. 1980; Zhang,
et al. 2015). In poultry, probiotics administration have been reported to improve weight gain
(Mountzouris, et al. 2007), to stimulate immune response (Zhang, et al. 2012), and to improve
food safety (Gaggìa, et al. 2010). However, due to complicated interactions and low numbers of
birds for statistical power more studies are urgently needed (Alloui, et al. 2013). Probiotic use in
swine has also suggested that probiotics do not improve weight gain nor feed efficiency (Harper,
et al. 1983; Lähteinen, et al. 2014). Taken together, probiotics could negatively impact host
growth performance due to the production of BSH enzymes. BSH inhibitor together with
probiotics could mitigate negative features of probiotics and optimize probiotic products for
enhanced growth performance of food animals and profitability of feed additive industry.
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Figure 1. Sequence and structural analysis of BSH.
(A) Phylogenetic relationship of BSH from different bacteria. The amino acid-based dendrogram
was constructed in MEGA 6.0 by using neighbor-joining methods. LaciP, L. acidophilus PF01
(ABQ01980.1); LsalN1, L. salivarius NRRL B-30514 BSH1 (JX120368); LsalN2, L. salivarius
NRRL B-30514 BSH2 (JX120369); LsalU1, L. salivarius UCC118 BSH1(ACL98201.1); LsalU2,
L. salivarius UCC118 BSH2 (ABD99327.1); LsalJ, L. salivarius JCM1046 BSH1 (ACL98203.1);
LaciN, L. acidophilus NCFM (AAV42923.1); Lgass, Lactobacillus gasseri (EFQ47028.1); Ljohn,
L. johnsonii (EGP12391.1); Lplan, L. plantarum (AAA25233.1); Bbifi, B. bifidum (AAR39435.1);
Blong, B. longum (AAF67801.1); Efaec, Enterococcus faecium (AAP20760.1); LmonM7, Listeria
monocytogenes M7(AEH93162.); Cperf, Clostridium perfringens (AAC43454.1); BPVA,
Bacillus Sphaericus PVA (YP_001698896). The number in parentheses is GenBank accession
number. Furthermore, the following sequences of BSH homologs were extracted from IMG
database (https://img.jgi.doe.gov/cgi-bin/w/main.cgi) based on similarity (>30%): Elimo,
Eubacterium limosum KIST612; Bprod, Blautia producta ATCC 27340; Sbovis, Streptococcus
bovis SN033; Panta, Planococcus antarcticus DSM 14505; Mbark, Microbacterium barkeri 2011R4; Prumi, Pseudobutyrivibrio ruminis HUN009; Cmalt, Carnobacterium maltaromaticum MX5;
Molle, Methanobrevibacter olleyae DSM 16632. (B) Structural modeling of BSH. Using C.
perfringens BSH as a template, the structures of L. acidophilus BSH (green backbone) and L.
salivarius BSH (red backbone) were predicted and superimposed. The RMSD value is 2.749 A.
The side chains of critical residues C2 and R16 were denoted.
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(A)

Figure 1. Continued
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(B)

Figure 1. Continued
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Figure 2. Production of purification of the L. acidophilus BSH enzyme.
Lane M, EZ RunTM prestained molecular mass marker (Fisher Bioreagent); Lane 1-12, eluted
fractions during Ni-nitrilotriacetic acid affinity chromatography purification; 0 hr, whole-cell
lysate of noninduced E. coli.; 1 hr, whole-cell lysate of E. coli induced with 0.5mM IPTG for 1 hr;
2 hr, whole-cell lysate of E. coli induced with 0.5mM IPTG for 2 hr.
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Figure 3. Dose-dependent effects of selected BSH inhibitors on the activity of the L.
acidophilus BSH.
(A) Inhibition of BSH activity by CAPE. (B) Inhibition of BSH activity by riboflavin.
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Riboflavin

(B)

Riboflavin

Figure 4. High-performance liquid chromatography analysis of riboflavin compound in
standard solution and in feed sample.
(A) Standard riboflavin (5 ppm) detected by HPLC (Peak 16.044: Riboflavin). (B) The riboflavin
detected in the treated Starter feed supplemented with high level of riboflavin (200 ppm) (Peak
16.066: Riboflavin)
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Figure 5. L. acidophilus BSH Substrate Preference.
Relative rBSH activity for various substrates when compared to the activity for
glycochenodeoxycholate (GCDC). GC: Glycocholate, GDC: Glycodeoxycholate, GCDC:
Glycochenodeoxycholate, TC: Taurocholate, TDC: Taurodeoxycholate, and TCDC:
Taurochenodeoxycholate
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Table 1. Composition of basal feed (Control) and the feed supplemented with low level of
riboflavin (20 ppm, Low) or high level of riboflavin (200 ppm, High) during the starter,
grower, and finisher phases.
Starter
0 to 14 d (as fed basis)

Corn, grain
Soybean meal
Alfalfa meal
Fish meal
Vitamin Premix1
Sand*
DL Methionine
Salt
Limestone
Dicalcium
phosphate
Trace Mineral
Premix2
Fat, animal
Riboflavin*
Calculated
Nutrition
Composition
ME, kcal/kg
Crude protein

Control
53.700
33.300
1.960
3.000
0.027
0.020
0.150
0.350
0.900
1.500

Low
53.700
33.300
1.960
3.000
0.027
0.018
0.150
0.350
0.900
1.500

High
53.700
33.300
1.960
3.000
0.027
0.000
0.150
0.350
0.900
1.500

Grower
15 to 32 d
(%)
Control
Low
61.2
61.2
25.8
25.8
1.960
1.960
3.000
3.000
0.027
0.027
0.020
0.018
0.150
0.150
0.350
0.350
0.900
0.900
1.500
1.500

Finisher
33 to 42 d

0.100

0.100

0.100

0.100

0.100

0.100

0.100

0.100

0.100

5.000
0.000

5.000
0.002

5.000
0.020

5.000
0.000

5.000
0.002

5.000
0.020

5.000
0.000

5.000
0.002

5.000
0.020

3,133
22.990

3,133
22.990

3,133
22.990

3,201
19.990

3,201
19.990

3,201
19.990

3,240
18.270

3,240
18.270

3,240
18.270

High
61.2
25.8
1.960
3.000
0.027
0.000
0.150
0.350
0.900
1.500

Control
65.5
21.5
1.960
3.000
0.027
0.020
0.150
0.350
0.900
1.500

Low
65.5
21.5
1.960
3.000
0.027
0.018
0.150
0.350
0.900
1.500

High
65.5
21.5
1.960
3.000
0.027
0.000
0.150
0.350
0.900
1.500

The corn-soybean formulation (reported in percentage) was used in the starter, grower, and finisher
diets for the 42 day large scale chicken experiment. Metabolizable energy increased as crude
protein decreased from the starter diet to the finisher.
*Riboflavin was supplemented at low (20 ppm) or high (200 ppm) levels at the expense of sand.
1

Supplied per kilogram of Starter diet: Vitamin A, 3,751 IU; Vitamin D, 1,191 ICU; Vitamin E 9
IU; Vitamin B12, 0.0048 mg; Menadione, 0.595 mg; Vitamin B2, 2.98 mg; Pantothenic Acid, 5 mg;
Niacin, 15 mg; Folic Acid, 0.298 mg; Vitamin B6, 0.893 mg; Thiamine, 0.417 mg.
2

Supplied per kilogram of Starter diet: Cobalt, 0.020 mg; Iodine, 2 mg; Selenium, 0.6 mg.

56

Table 2. Effect of identified BSH inhibitors on the activity of the L. acidophilus BSH enzyme.
Compound Category
a
The approved feed
additives used in food
animal industry (Wang,
et al. 2012)

b

The novel BSH
inhibitors identified
using high-throughput
screening (Smith, et al.
2014)
d

The antibiotics that
can inhibit BSH
activity (Smith, et al.
2014)

BSH Inhibitor
KIO3
NaHIO3
NaIO4
CuSO4
CuCl2
ZnSO4
ZnCl2
Menadione
Riboflavinc
Gossypetin
Caffeic Acid Phenethyl Ester (CAPE)
Epicatechin monogallate
Purpurogallin
Oxytetracycline
Demeclocycline Hydrochloride
Methacycline Hydrochloride
Doxycycline Hydrochloride
Roxarsone
Lincomycin

% Inhibition
99.1
99.3
99.0
94.7
97.2
27.4
38.4
97.9
96.5
96.1
71.8
52.8
36.1
99.6
99.6
99.2
98.3
48.6
26.8

a

The final concentration of dietary compound in the reaction mix was 5mM to achieve optimal
resolution with the quantitative BSH activity assay.
b

Unless specified, the final concentration of specific BSH inhibitor was 2.5 mM.

c

The final concentration of riboflavin in reaction mix was 0.5 mM.

d

The final concentration of specific antibiotic was 2.5 mM.
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Table 3. Summary of the growth performance of broiler in response to riboflavin treatment.

Chicken Age
(Day)
14
21
28
33
42

0.3369
0.4605 a
0.6847
0.4588
0.7943
Chicken Age
(Day)

14
21
28
33
42
Chicken Age
(Day)
14
21
28
33
42
Chicken Age
(Day)
07
14
21
28
33
42
ab

BW Gain (kg/bird per week)
Control
Low
High
0.3381
0.3099
0.4966 b
0.5103 b
0.6592
0.6443
0.4490
0.4199
0.8053
0.8274
Feed Intake (kg/bird per week)
Control
Low
High

Standard
Error
±0.010
±0.010
±0.020
±0.020
±0.030
Standard
Error
±0.010
±0.020
±0.020
±0.170
±0.050

0.4101 a
0.3964 ab
0.3759 b
0.7799 a
0.7601 a
0.8847 b
1.0536
1.0448
1.0384
0.8196
0.8067
0.7810
1.7548
1.7505
1.7946
Feed Conversion Ratio (kg of gain/ kg of feed per bird)
Control
Low
High
Standard
Error
0.8217
0.8560
0.8261
±0.020
0.5925 a
0.6546 b
0.5789 a
±0.010
0.6504
0.6313
0.6206
±0.010
0.5591
0.5569
0.5364
±0.010
0.4519
0.4614
0.4657
±0.020
Average BW (kg/bird)
Control
Low
High
Standard
Error
0.1753
0.1739
0.1695
±0.002
0.5122
0.5062
0.4794
±0.010
0.9727
1.0027
0.9897
±0.010
1.6813
1.6867
1.6340
±0.010
2.1204
2.1357
2.0539
±0.030
2.9147
2.9409
2.8861
±0.040

P value
0.1137
0.0053
0.1825
0.1893
0.7786
P value
0.0393
0.0001
0.7765
0.2701
0.7965
P value
0.5638
0.0030
0.2744
0.4039
0.8774
P value
0.2431
0.0842
0.1849
0.0968
0.0655
0.6225

Effects means within columns with no common superscript differ significantly (P < 0.05)
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Table 4. Determination of riboflavin level in feed using high performance liquid
chromatography.
Feed
Starter
Grower
Finisher

Concentration of Riboflavin (mg/kg of feed) ±SD
Control
Low
High
39.15 ±20.11
51.55 ±21.42
128.87 ±37.90
34.06 ±6.20
40.57 ±11.12
144.55 ±28.27
26.79 ±4.31
31.86 ±15.74
116.44 ±15.74

Riboflavin levels were detected in each of the starter, grower, and finisher treatment paradigms
in two independent HPLC experiments.
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Table 5. Total bile salt levels in serum and ileal samples of chickens.
Sample
Type

Serum
(umole/L)

Ileal
(umole/g)

Age
(Day)

14
33
42
14
33
42

Levels of Total Bile
Control
27.01
17.16
16.98
256.64
87.90
149. 15

Low
27.24
15.00
21.43
113.39
108.60
361.81

High
31.23
16.88
15.71
208.50
140.85
334.54
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Pooled
Standard
Error

P value

±3.64
±2.06
±2.77
±104.55
±32.21
±126.05

0.6810
0.7268
0.3248
0.6202
0.4638
0.4481
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